trending Market Intelligence /marketintelligence/en/news-insights/trending/O_w7FtKzorlgyjrnoPk11g2 content esgSubNav
In This List

Arrowhead Pharmaceuticals appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Arrowhead Pharmaceuticals appoints director

Arrowhead Pharmaceuticals Inc. appointed William Waddill as an independent director, effective Jan. 1, 2018.

Most recently, Waddill was senior vice president and CFO of Calithera Biosciences Inc.